Research register

What the studies actually found.

Nine independent studies and reviews of evening light, amber lenses and blue-light filtering — each with the design, sample size and measurements it was published with.

SleepSpec was engineered from the mechanism these studies describe. They tested evening light and blue-light filtering rather than SleepSpec itself — so here they are, reported as published.

How to read this

Evidence is not one thing.

Study design

An uncontrolled before-and-after study shows that something changed over time. A randomised crossover trial compares the same people under two conditions, which rules out far more. Both appear below, each labelled with what it was.

Sample size

These are small trials: 12 to 72 participants, plus two workplace studies of 63 and 67 people. Sample sizes like these show a direction clearly. They are not large enough to fix an exact number.

What was measured

Reported sleep and instrument-measured sleep do not always agree. Every entry names its measurement channels, so you can see which is which.

  • Melatonin
  • Self-reported

Solid: measured by instrument or assay. Dashed: reported by the participants themselves.

The mechanism

Why evening light is the variable.

Evening exposure to short-wavelength, melanopically effective light — including blue and cyan light — can suppress melatonin and, depending on its timing, intensity and duration, delay circadian timing and sleep onset.

Human circadian photoreception is especially sensitive to short-wavelength visible light. The melanopsin photopigment peaks at approximately 479–480 nm, while the standardised melanopic action spectrum at the eye peaks at approximately 490 nm.

Age changes the input. Younger crystalline lenses generally transmit more short-wavelength light to the retina, while ageing causes the lens to become yellower and selectively reduce short-wavelength transmission.

How evening light works, in full →
Melanopic sensitivity against the SleepSpec filtration range A schematic sensitivity curve peaking at approximately 490 nanometres, shown against a shaded band covering 400 to 520 nanometres, the range in which the SleepSpec lens blocks 98% of blue-green light. 400 450 500 550 600 650 700 ≈490 nm — melanopic peak at the eye melanopic sensitivity 400–520 nm — 98% blocked wavelength
Schematic. Peak wavelengths are as published; the curve shape is illustrative. The shaded band is the SleepSpec filtration range: 98% ± 2% blue-green-light filtration across 400–520 nm.

The register

Nine studies, in full.

Grouped by what each one was actually asking. Findings are given in the researchers’ own terms, including the ones that came back negative.

What evening light does

2015

Four hours of light-emitting reading before bed

Reading from a light-emitting e-reader for four hours before bed on five consecutive evenings suppressed melatonin, delayed circadian timing, reduced evening sleepiness and increased sleep-onset latency, compared with reading a printed book.

A controlled laboratory comparison: four hours of screen reading against four hours of print, on five consecutive evenings.

Design
Laboratory crossover
Participants
12 adults, 5 evenings per condition
Measures
  • Melatonin
  • Circadian timing
  • Self-reported
Source
Chang et al., 2015 · PNAS

2023

How much melanopic light a display actually delivers

Higher melanopic irradiance reaching the eye from evening displays produced greater melatonin suppression, later melatonin onset and longer sleep-onset latency. The effect tracked the melanopic dose rather than the screen itself.

Measured in healthy men, and about melanopic light reaching the eye rather than any particular pair of glasses.

Design
Controlled laboratory study
Participants
72 healthy men
Measures
  • Melatonin
  • Sleep latency
Source
Schöllhorn et al., 2023 · Communications Biology

What happened when people wore filtering lenses

2017

Two weeks of evening short-wavelength blocking

Night-time melatonin increased from 16.1 to 25.5 pg/mL — approximately 58% — and actigraphy-estimated sleep duration increased by approximately 23 minutes after two weeks of evening short-wavelength-blocking glasses.

An uncontrolled pre–post design: all 21 participants wore the glasses, with no comparison group.

Design
Uncontrolled pre–post
Participants
21 participants, 2 weeks
Measures
  • Melatonin
  • Actigraphy
Source
Ostrin et al., 2017 · University of Houston

2018

Amber against clear, in adults with insomnia symptoms

Amber lenses worn for two hours before bed increased self-reported sleep by approximately 52 minutes and actigraphy-estimated sleep by approximately 29 minutes compared with clear lenses, while also improving insomnia scores and perceived sleep quality.

Fourteen participants, all with insomnia symptoms. Both measures moved, the reported gain being roughly twice the actigraphy-estimated one.

Design
Randomised crossover, amber vs clear
Participants
14 adults with insomnia symptoms
Measures
  • Actigraphy
  • Self-reported
  • Insomnia score
Source
Shechter et al., 2018 · Columbia University

2021

Healthy adults: what people felt, and what the instruments saw

Blue-light-blocking glasses reduced self-reported sleep-onset latency from 24 to 21 minutes and reported awakenings from 2.2 to 1.6 per night. Objective sleep measures did not significantly improve.

Healthy adults rather than people with sleep difficulties, with the reported measures moving further than the objective ones.

Design
Randomised crossover
Participants
20 healthy adults
Measures
  • Objective sleep
  • Self-reported
Source
Bigalke et al., 2021 · Montana State University

2021

Two workplaces, one result that did not repeat

Two experimental studies reported better sleep and improvements in some next-day outcomes, including work engagement and task performance. Stronger effects among later chronotypes appeared in the manager study, but were not replicated in the call-centre study.

Field studies in real workplaces, measured through participant reports and next-day work outcomes rather than sleep instruments.

Design
Two experimental field studies
Participants
63 managers · 67 call-centre employees
Measures
  • Self-reported
  • Work outcomes
Source
Guarana, Barnes & Ong, 2021 · Journal of Applied Psychology

2021

Third-trimester pregnancy

Melatonin onset occurred approximately 28 minutes earlier with blue-blocking glasses than with partially blocking control glasses. Melatonin onset was calculated for 47 of the participants, and primary sleep outcomes did not significantly improve.

A specific population — third-trimester pregnancy — with melatonin onset calculated for 47 of the 60 participants.

Design
Randomised trial vs partially blocking control
Participants
60 healthy nulliparous women
Measures
  • Melatonin onset
  • Sleep outcomes
Source
Liset et al., 2021 · University of Bergen

What the reviewers concluded

2021
and later

Two reviews, two verdicts

A 2021 systematic review concluded that there was “substantial evidence” for reduced sleep-onset latency among people with sleep disorders, jet lag or variable shift-work schedules. A later Cochrane review judged the overall sleep evidence mixed and very uncertain.

Two teams weighing the same literature to different standards. Both conclusions are given here.

Design
Systematic review · Cochrane review
Scope
Sleep disorders, jet lag and shift work; then the general evidence base
Source
Systematic review, 2021, and a later Cochrane review

2025

Twenty-six products on the market, measured

An optical analysis of 26 commercially available glasses described appropriately selected blue-blocking glasses as a potentially low-cost, individualised tool for supporting sleep and circadian health, while emphasising that effectiveness depends on spectral filtering, timing and correct use.

An analysis of lenses rather than a sleep trial. Its three conditions — spectral filtering, timing and correct use — are the ones a buyer can check.

Design
Optical analysis
Scope
26 commercially available glasses
Measures
  • Spectral filtering
Source
Glickman et al., 2025 · Translational Vision Science & Technology

Where SleepSpec fits

Engineered from the mechanism. Measured as a product.

These studies describe the mechanism SleepSpec was built around: how evening light reaches the body clock, and what changed when researchers filtered it. They were not run on SleepSpec, so what SleepSpec states precisely is what its lens does.

That part is a measurement, not a forecast.

SleepSpec glasses beside open research material on a dark desk.
98%Blue-green light blocked, 98% ± 2%
400–520 nmFiltration range, across the melanopic sensitivity zone
Deep amberPreserves more natural colour than dark-red lenses

Timing is the condition the research keeps returning to. Wear them 1–2 hours before bed, and take them off at lights-out.

Sources

References

  1. Chang, Aeschbach, Duffy & Czeisler (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. PNAS.
  2. Schöllhorn et al. (2023). Melanopic irradiance defines the impact of evening display light on sleep latency, melatonin and alertness. Communications Biology.
  3. Ostrin, Abbott & Queener (2017). Attenuation of short wavelengths alters sleep and the ipRGC pupil response. Ophthalmic & Physiological Optics.
  4. Shechter et al. (2018). Blocking nocturnal blue light for insomnia: a randomised controlled trial. Journal of Psychiatric Research.
  5. Bigalke et al. (2021). Effect of evening blue-light-blocking glasses on subjective and objective sleep in healthy adults. Sleep Health.
  6. Guarana, Barnes & Ong (2021). The effects of blue-light filtration on sleep and work outcomes. Journal of Applied Psychology.
  7. Liset et al. (2021). A randomised controlled trial on blue-blocking glasses during third-trimester pregnancy. Neurobiology of Sleep and Circadian Rhythms.
  8. Glickman et al. (2025). Optimizing the potential utility of blue-blocking glasses for sleep and circadian health. Translational Vision Science & Technology.
  9. The two evidence syntheses in “What the reviewers concluded” are a 2021 systematic review and a later Cochrane review.

SleepSpec is not a medical device and is not intended to diagnose, treat, cure or prevent any condition. Individual results vary.